Healthcare startup Bonatra said it had acquired women’s health and wellness company MyAva for an undisclosed amount. The company stated that it aims to expand its holistic healthcare programmes with this acquisition and develop into a one-stop platform for managing chronic health conditions.
MyAva is a startup which empowers women to manage chronic health conditions like polycystic ovary syndrome (PCOS), thyroid disorders, insulin resistance and more.
Among other chronic diseases, Bonatra focuses on managing and treating diabetes, hypertension, fatty liver, PCOD, obesity, and other conditions.
“Acquiring MyAva enables us to expand our reach and deepen our expertise in women’s health,” Bonatra CEO and co-founder Rahul Kishore Singh stated.
According to MyAva founder and CEO Evelyn Immanuel, the move improves the goal of making chronic care management accessible to all women.
“We believe this further strengthens our combined commitment towards making femtech more inclusive and integrated,” she added.